Steadfast Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Steadfast Capital Management's RGEN Position: Q1 2026 in Review
Steadfast Capital Management sold out of Repligen (RGEN) in Q1 2026, closing a stake of 45,300 shares — an estimated $7.42M sold.
Steadfast Capital Management first reported a position in RGEN in Q4 2025 and held it in 1 quarter. The position peaked at $7.42M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Steadfast Capital Management reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
- Steadfast Capital Management sold 45,300 Repligen shares in Q1 2026, an estimated $7.42M.
- Steadfast Capital Management first reported a position in Repligen in Q4 2025 and held it in 1 quarter.
- Steadfast Capital Management's Repligen position peaked at $7.42M in Q4 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Steadfast Capital Management's 13F filing for Q1 2026, filed 15 May 2026.